The GLP is committed to full transparency. Download and review our 2019 Annual Report

Doctors turn to stem cell regeneration to treat heart defects in babies

| | December 21, 2016

The GLP posts this article or excerpt as part of a daily curated selection of biotechnology-related news, opinion and analysis.

The 4-month-old on the operating table has a shocking birth defect, nearly half his heart too small or even missing…In a bold experiment, doctors injected donated stem cells directly into the healthy side of [his] little heart, aiming to boost its pumping power as it compensates for what’s missing.

It’s one of the first attempts in the U.S. to test if stem cells that seem to help heart attack survivors repair cardiac muscle might help these tiniest heart patients, too.

[D]octors are conducting this early-stage study of whether stems cells might help that ventricle work better.

“This is very different than a surgical approach or giving a medicine just to treat the symptoms. This is trying to treat the underlying problem,” Dr. Kristin Burns, a pediatric cardiologist at the National Institutes of Health.

Even in adults, stem cell regeneration is highly experimental. But small studies involving heart attack survivors and older adults with heart failure have found what Dr. Denis Buxton, a stem cell specialist at NIH’s heart institute, calls a modest benefit in how well their hearts pump blood.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: Testing Stem Cells in Tiniest Hearts to Fight Birth Defect

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend